Exact Sciences Q3 Adjusted Net Income, Revenue Rise; Shares Gain After Hours
MT Newswires Live
Nov 04, 2025
Exact Sciences (EXAS) reported Q3 adjusted net income late Monday of $0.24 per diluted share, up from $0.07 a year earlier.
Analysts polled by FactSet expected $0.15.
Revenue in the three months ended Sept. 30 rose to $850.7 million from $708.7 million a year earlier.
Analysts polled by FactSet expected $810.5 million.
The company raised 2025 revenue guidance to the range of $3.22 billion to $3.235 billion from $3.13 billion to $3.17 billion.
Analysts polled by FactSet project $3.16 billion.
The company's shares rose 6.8% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.